Part of Evidera’s global marketing access consulting group in London, Tim has experience in global pricing, reimbursement and market access strategy development. He brings over 10 years of global pricing and market access communications expertise and has led more than 400 global research projects. He also brings 12 years’ pricing and reimbursement experience gained from global, European and U.K. pricing, reimbursement and health economics positions within the pharmaceutical sector.
Tim formerly was global pricing and market access director with responsibility for CRESTOR, Seroquel and the emerging cardiovascular, inflammation and oncology portfolios at AstraZeneca. Other positions in the industry include head of health economics and outcomes research at Janssen-Cilag U.K. and European pricing and reimbursement for Botox at Allergan.
Tim received a bachelor’s in economics, jointly with public administration, and he has a post-graduate degree in health economics.